These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 8488316)

  • 1. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peripheral and cardiac adaptive mechanisms in heart failure: the role of the renin-angiotensin system and its inhibition].
    Drexler H
    Verh Dtsch Ges Inn Med; 1991; 97():552-7. PubMed ID: 1808945
    [No Abstract]   [Full Text] [Related]  

  • 3. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors.
    Herlihy BL; Herlihy JT
    Crit Care Nurse; 1990 Mar; 10(3):74-7. PubMed ID: 2357893
    [No Abstract]   [Full Text] [Related]  

  • 5. [ACE inhibitors in hypertension and heart failure].
    Riegger AJ
    Internist (Berl); 1992 Oct; 33(10):639-44. PubMed ID: 1428682
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress in angiotensin-converting enzyme inhibition in heart failure: rationale, mechanisms, and clinical responses.
    Dzau VJ; Creager MA
    Cardiol Clin; 1989 Feb; 7(1):119-30. PubMed ID: 2650868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
    Pichler M; Klein W; Huber K; Pachinger O
    Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiotensin-converting enzyme (ACE) inhibitors in cardiac decompensation; from randomized study to individual patient].
    van Vlies B
    Ned Tijdschr Geneeskd; 1992 Sep; 136(37):1796-8. PubMed ID: 1407135
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M; Solomon SD
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical pharmacology of angiotensin II antagonists].
    Arabidze GG; Novikova LS
    Farmakol Toksikol; 1990; 53(2):80-6. PubMed ID: 2369961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
    Schofer J
    Dtsch Med Wochenschr; 1988 Oct; 113(43):1684-9. PubMed ID: 2846252
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of heart failure with angiotensin converting enzyme inhibitors. Effects on renal function].
    Osterziel KJ; Dietz R; Kübler W
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1082-5. PubMed ID: 2661192
    [No Abstract]   [Full Text] [Related]  

  • 14. [Angiotensin-converting enzyme inhibitors. Principles and rules of use].
    Eicher JC; Wolf JE
    Rev Prat; 1998 Apr; 48(7):771-6. PubMed ID: 11767373
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
    Karlsen FM; Kamper AL
    Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833
    [No Abstract]   [Full Text] [Related]  

  • 16. [In the age of ACE inhibitors are there still indications for spironolactone in heart failure?].
    Böhm M
    Internist (Berl); 1995 Feb; 36(2):179-80. PubMed ID: 7737809
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
    Krakoff LR; Rajasekharaiah V
    Mt Sinai J Med; 1998 Mar; 65(2):125-32. PubMed ID: 9520516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.